Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Carotid and Renal Artery Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Carotid and Renal Artery Stents under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Carotid and Renal Artery Stents and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Carotid and Renal Artery Stents under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Carotid and Renal Artery Stents Overview
3 Products under Development
3.1 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
3.2 Carotid and Renal Artery Stents - Pipeline Products by Segment
3.3 Carotid and Renal Artery Stents - Pipeline Products by Territory
3.4 Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
3.5 Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
3.6 Carotid and Renal Artery Stents - Ongoing Clinical Trials
4 Carotid and Renal Artery Stents - Pipeline Products under Development by Companies
4.1 Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
4.2 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
5 Carotid and Renal Artery Stents Companies and Product Overview
5.1 Acotec Scientific Holdings Ltd Company Overview
CGuard Embolic Prevention System - Product Description
Next Gen CGuard - 5F - Product Status
Next Gen CGuard - 5F - Product Description
RGuard Renal - Product Status
RGuard Renal - Product Description
InspireMD Inc - Ongoing Clinical Trials Overview
CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
Loyola University Chicago Pipeline Products & Ongoing Clinical Trials Overview
Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Carotid Artery Stent - Product Status
Carotid Artery Stent - Product Description
Shanghai HeartCare Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Carotid Artery Stent - The Safety and Efficacy of Carotid Artery Stenting in Carotid Stenosis: A Prospective Multicenter, Non-inferiority Design, Randomized, Controlled Clinical Trial